• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Nutex Health Inc.

    6/26/24 4:28:47 PM ET
    $NUTX
    Real Estate
    Real Estate
    Get the next $NUTX alert in real time by email
    S-8 1 nutx_s8.htm FORM S-8

    As filed with the Securities and Exchange Commission on June 26, 2024

    Registration No. 333-

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM S-8

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

    NUTEX HEALTH INC.
    (Exact Name of Registrant as Specified in its Charter)

    Delaware

    (State or other jurisdiction of incorporation or organization)

    11-3363609

    (I.R.S. Employer Identification No.)

    6030 S. Rice Ave, Suite C
    Houston, TX 77081
    (Address of principal executive offices) (Zip code)

    Amended and Restated Nutex Health Inc. 2023 Equity Incentive Plan
    (Full title of the plan)

    Elisa V. Luqman
    Chief Legal Officer – SEC
    6030 S. Rice Ave, Suite C
    Houston, TX 77081
    (Name and address of agent for service)

    (713) 660-0557
    (Telephone number, including area code, of agent for service)

    Copies to:

    Gislar Donnenberg
    Joe Perillo

    Locke Lord LLP

    600 Travis St., Suite 2800

    Houston, Texas 77002

    (713) 226-1200

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

    Large accelerated filer ☐ Accelerated filer ☒
    Non-accelerated filer ☐ Smaller reporting company ☒
      Emerging growth company ☐
       

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     
     

    EXPLANATORY NOTE

    This Registration Statement on Form S-8 (this “Registration Statement”) is being filed with the Securities and Exchange Commission (the “Commission”) by Nutex Health Inc. (the “Company” or the “Registrant”) for the purpose of registering 451,362 additional shares of the Company’s common stock, par value of $0.001 per share (the “Common Stock”), that were automatically added on January 1, 2024 to the number of shares authorized for issuance under the Nutex Health Inc. Amended and Restated 2023 Equity Incentive Plan (the “2023 Plan”), pursuant to an “evergreen” provision, which allows for an annual increase of the overall share limit on the first day of each calendar year beginning on and including January 1, 2024 equal to the lesser of (i) 1% of the aggregate number of shares of Common Stock outstanding on the final day of the immediately preceding calendar year and (ii) such smaller number of shares as is determined by the Company’s board.

    Pursuant to the Company’s Registration Statement on Form S-8 (File No. 333-267710) filed by the Registrant on September 30, 2022, and Registration Statement on Form S-8 (File No. 333-273402) filed by the Registrant on July 25, 2023 (the “Prior Registration Statements”), the Registrant previously registered an aggregate of 734,263 shares of Common Stock (as adjusted for the Reverse Split of 1 for 15 effected by the Company effective April 10, 2024) under the 2023 Plan. The additional shares of Common Stock being registered by this Registration Statement are of the same class as those securities registered on the Prior Registration Statements. In accordance with General Instruction E of Form S-8, the contents of the Prior Registration Statements, together with all exhibits filed therewith or incorporated therein by reference to the extent not otherwise amended or superseded by the contents hereof or otherwise, are incorporated herein by reference.

     
     

    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 3.Incorporation of Documents by Reference.

    The following documents, filed by the Company with the Commission pursuant to the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) are incorporated by reference in, and shall be deemed to be a part of, this Registration Statement:

    ·Annual report on Form 10-K for the year ended December 31, 2023, as filed with the Commission on March 29, 2024, and amended on Form 10-K/A as filed with the Commission on April 30, 2024;

     

    ·Quarterly report on Form 10-Q for the quarter ended March 31, 2024 filed with the Commission on May 9, 2024;

     

    ·Current reports on Form 8-K filed on January 24, 2024, February 9, 2024, February 15, 2024, February 29, 2024, April 8, 2024, April 11, 2024, May 24, 2024 and June 18, 2024; and

     

    ·The description of the Company’s common stock, par value $.001 per share, contained in Exhibit 4.6 to Nutex’s quarterly report on Form 10-Q for the period ended June 30, 2022, filed on August 22, 2022.

    In addition, all documents filed by the Registrant pursuant to Section 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents or portions thereof that are “furnished” and not “filed” in accordance with the rules of the Commission, shall not be deemed to be incorporated by reference in this Registration Statement.

    Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

    Item 8.Exhibits.

    The following exhibits are filed as part of this Registration Statement:

           

    Incorporation by Reference

    (File No. 001-41346)

     
    Exhibit Number   Description   Form   Exhibit   Filing
    Date
                     
    3.1   Second Amended and Restated Certificate of Incorporation of the Registrant.   8-K   3.1   7/5/2023
    3.2   Amendment to the Second Amended and Restated Certificate of Incorporation.   8-K   3.1   4/11/2024
    3.3   Second Amended and Restated Bylaws.   8-K   3.2   4/4/2022
    5.1*   Opinion of Locke Lord  LLP            
    10.2   Amended and Restated Nutex Health Inc. 2023 Equity Incentive Plan.   Schedule 14A   Appendix A   5/19/2023
    23.1*   Consent of Marcum LLP, independent registered public accounting firm            
    23.2*   Consent of Locke Lord LLP (contained in Exhibit 5.1)            
    107*   Filing Fee Table            

    __________

    * Filed herewith

     
     

     

    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Houston, State of Texas, on the 26th day of June, 2024.

      NUTEX HEALTH INC.
       
       By: /s/ Thomas T. Vo
        Thomas T. Vo, M.D.
    Chief Executive Officer

     

     

     

     
     

     

    SIGNATURES AND POWER OF ATTORNEY

    Each person whose signature appears below constitutes and appoints each of Thomas T. Vo, M.D. and Jon C. Bates, acting alone or together with another attorney-in-fact, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in his or her name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully and to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities held on the dates indicated.

    June 26, 2024 /s/ Thomas T. Vo
      Thomas T. Vo
     

    Chief Executive Officer and Chairman of the Board

    (principal executive officer)

       
    June 26, 2024 /s/ Jon C. Bates
      Jon C. Bates
     

    Chief Financial Officer

    (principal financial officer and principal accounting officer)

       
    June 26, 2024 /s/ Warren Hosseinion
      Warren Hosseinion
      President and Director
       
    June 26, 2024 /s/ Kelvin Spears
      Kelvin Spears
      Director
       
    June 26, 2024 /s/ Cheryl Grenas
      Cheryl Grenas
      Director
       
    June 26, 2024 /s/ Michael L. Reed
      Michael L. Reed
      Director
       
    June 26, 2024 /s/ Mitchell Creem
      Michell Creem
     

    Director

     

    June 26, 2024 /s/ Scott Saunders
      Scott Saunders
      Director

     

    Get the next $NUTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NUTX

    DatePrice TargetRatingAnalyst
    11/12/2024$45.00 → $50.00Buy
    Maxim Group
    9/18/2024$45.00Buy
    Maxim Group
    2/22/2023$3.00Outperform
    Northland Capital
    More analyst ratings

    $NUTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Saunders Scott J

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 1:04:42 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Director Reed Michael Lee

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 1:01:09 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Director Grenas Cheryl Yvonne

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 12:56:37 PM ET
    $NUTX
    Real Estate

    $NUTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NUTEX HEALTH RE-OPENS BAYOU CITY ER & HOSPITAL IN HOUSTON

    HOUSTON, Jan. 12, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced the reopening of Bayou City ER & Hospital, located northeast of Houston at 19211 McKay Dr., Humble, Texas. The staff of medical experts at Bayou City ER & Hospital are bringing the community 24/7/365 days of concierge-level care. The 40,000 square foot state-of-the-art facility houses 8 Emergency Room beds and 46 inpatient beds. It features a full-service laborat

    1/12/26 5:30:00 AM ET
    $NUTX
    Real Estate

    NUTEX HEALTH TO ATTEND AND PRESENT AT THE 2026 J.P. MORGAN HEALTHCARE CONFERENCE IN JANUARY IN SAN FRANCISCO

    HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that the Company's CEO, Dr. Tom Vo, CFO, Mr. Jon Bates, and President, Dr. Warren Hosseinion will attend and present at the 2026 J.P. Morgan Healthcare Conference on January 12-15 in San Francisco, California. Presentation Details: Speaker: Tom Vo, M.D., MBA, Chairman of the Board & CEODate: Wednesday, January 14, 2026Time: 4:30 PM PSTLocation: The Westin St. Fran

    1/5/26 5:30:00 AM ET
    $NUTX
    Real Estate

    NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS

    HOUSTON, Dec. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced the opening of its 26th hospital in a new state: Missouri. Archview ER & Hospital is located at 1320 N. Jefferson Ave. in St. Louis. The staff of medical experts at Archview ER & Hospital are bringing the community 24/7/365 days of concierge-level care. The 16,000 square foot state-of-the-art facility houses 15 Emergency Room beds and 3 inpatient suites. It featu

    12/22/25 5:30:00 AM ET
    $NUTX
    Real Estate

    $NUTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group reiterated coverage on Nutex Health with a new price target

    Maxim Group reiterated coverage of Nutex Health with a rating of Buy and set a new price target of $50.00 from $45.00 previously

    11/12/24 8:15:57 AM ET
    $NUTX
    Real Estate

    Maxim Group initiated coverage on Nutex Health with a new price target

    Maxim Group initiated coverage of Nutex Health with a rating of Buy and set a new price target of $45.00

    9/18/24 8:12:45 AM ET
    $NUTX
    Real Estate

    Northland Capital initiated coverage on Nutex Health with a new price target

    Northland Capital initiated coverage of Nutex Health with a rating of Outperform and set a new price target of $3.00

    2/22/23 9:08:40 AM ET
    $NUTX
    Real Estate

    $NUTX
    SEC Filings

    View All

    Nutex Health Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Nutex Health, Inc. (0001479681) (Filer)

    11/24/25 4:52:11 PM ET
    $NUTX
    Real Estate

    Nutex Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Nutex Health, Inc. (0001479681) (Filer)

    11/19/25 4:07:53 PM ET
    $NUTX
    Real Estate

    SEC Form 10-Q filed by Nutex Health Inc.

    10-Q - Nutex Health, Inc. (0001479681) (Filer)

    11/19/25 4:07:19 PM ET
    $NUTX
    Real Estate

    $NUTX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Bates Jon Christian bought $102,532 worth of shares (750 units at $136.71), increasing direct ownership by 15% to 5,638 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    11/28/25 2:11:24 PM ET
    $NUTX
    Real Estate

    Chief Financial Officer Bates Jon Christian converted options into 1,611 shares and bought $81,810 worth of shares (1,000 units at $81.81), increasing direct ownership by 115% to 4,888 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    4/14/25 4:30:48 PM ET
    $NUTX
    Real Estate

    Chief Financial Officer Bates Jon Christian bought $28,970 worth of shares (1,350 units at $21.46), increasing direct ownership by 146% to 2,277 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    8/26/24 11:54:30 AM ET
    $NUTX
    Real Estate

    $NUTX
    Leadership Updates

    Live Leadership Updates

    View All

    NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF WESLEY BAMBURG AS ITS NEW CHIEF OPERATING OFFICER

    HOUSTON, Sept. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments  in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Wesley Bamburg as the Company's Chief Operating Officer, effective October 13, 2025. Mr. Bamburg is an accomplished healthcare executive with 20 years of Fortune 500 experience in healthcare operations, business development, integrated network management, and physician relations. Mr. Bamburg has served as Chief Operating Officer for HCA Houst

    9/22/25 6:30:00 AM ET
    $NUTX
    Real Estate

    NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR

    HOUSTON, May 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm to replace CBIZ CPAs ("CBIZ"), effective May 15, 2025. The change of the Company's independent auditor was made after careful consideration and an evaluation process and was approved by the Audit Committee and the Board of Directors of the

    5/22/25 6:30:00 AM ET
    $NUTX
    Real Estate

    NUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

    HOUSTON, April 22, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Scott J. Saunders, and Kelvin Spears, MD, to its Board of Directors.  They replace John Waters, who recently passed away, and Dr. Daniel Stites, who fulfilled his one-year term Board commitment. The Board has determined that Mr. Saunders satisfies the current independent director standards established by the rules of The Nasdaq Stock Market. Mr. Saunders will s

    4/22/24 5:30:00 AM ET
    $NUTX
    Real Estate

    $NUTX
    Financials

    Live finance-specific insights

    View All

    NUTEX HEALTH REPORTS SEPTEMBER 30, 2025 THIRD QUARTER AND YEAR-TO-DATE FINANCIAL RESULTS

    Total revenue of $723.6 million for the first nine months of 2025 versus $222.3 million for the first nine months of 2024, an increase of 225.5%Net income attributable to Nutex Health Inc. of $59.0 million for the first nine months of 2025 versus net loss of $9.5 million for the first nine months of 2024, an increase of $68.5 millionDiluted income per share of $8.87 for the first nine months of 2025 versus a loss per share of $1.91 for the first nine months of 2024EBITDA of $142.9 million for the first nine months of 2025 versus $19.9 million for the first nine months of 2024, an increase of 616.4%Adjusted EBITDA of $243.0 million for the first nine months of 2025 versus $16.1 million for th

    11/19/25 4:30:00 PM ET
    $NUTX
    Real Estate

    NUTEX HEALTH PROVIDES FINANCIAL REPORTING UPDATE

    HOUSTON, Aug. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today disclosed non-reliance on its (i) unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2025 contained in the Form 10-Q for the period ended March 31, 2025 (the "Original Form 10-Q") and its (ii) audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 contained in the Form 10-K for the

    8/20/25 6:51:00 PM ET
    $NUTX
    Real Estate

    NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION

    HOUSTON, Aug. 14, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will delay filing its Form 10-Q for the period ending June 30, 2025 due to non-cash accounting adjustments related to the treatment of stock based compensation obligations for certain under-construction and ramping hospitals, as disclosed in previous filings. The Company additionally provided preliminary financial results for the three and six months ended

    8/14/25 5:10:00 PM ET
    $NUTX
    Real Estate

    $NUTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Nutex Health Inc.

    SC 13G - Nutex Health, Inc. (0001479681) (Subject)

    11/14/24 11:02:17 AM ET
    $NUTX
    Real Estate

    SEC Form SC 13G/A filed by Nutex Health Inc. (Amendment)

    SC 13G/A - Nutex Health, Inc. (0001479681) (Subject)

    9/26/23 4:26:07 PM ET
    $NUTX
    Real Estate

    SEC Form SC 13G filed by Nutex Health Inc.

    SC 13G - Nutex Health, Inc. (0001479681) (Subject)

    7/7/23 5:03:39 PM ET
    $NUTX
    Real Estate